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Abstract: The best-defined primary esophageal motor disorder is achalasia. However, symptoms
such as dysphagia, regurgitation and chest pain can be caused by other esophageal motility
disorders. The Chicago classification introduced new manometric parameters and better defined
esophageal motility disorders. Motility disorders beyond achalasia with the current classification
are: esophagogastric junction outflow obstruction, major disorders of peristalsis (distal esophageal
spasm, hypercontractile esophagus, absent contractility) and minor disorders of peristalsis (ineffective
esophageal motility, fragmented peristalsis). The aim of this study was to review the current diagnosis
and management of esophageal motility disorders other than achalasia.
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1. Introduction
The best-defined primary esophageal motor disorder is achalasia. However, symptoms such
as dysphagia, regurgitation and chest pain can be caused by other esophageal motility disorders.
Unfortunately, while there is a reasonable consensus on the pathophysiology, diagnosis and treatment
of achalasia, this has not occurred for other motility disorders [1].
Esophageal manometry, the best method to evaluate esophageal motility, evolved from
intraluminal balloons to water perfused catheters, and then to solid state probes; from unidirectional
measurements to circumferential data gathering; and from simple pressure curves to intuitive colorful
temporal-pressure plots. This technological evolution led to the development of high-resolution
manometry (HRM) [2].
The more comprehensive HRM plots provoked esophageal physiologists to develop new
manometric parameters and reclassify esophageal motility disorders. This led to a compilation of
significant clinical findings under the Chicago classification [3]. This classification was recently revised
(version 3.0) to exclude some previous parameters without clear clinical application, characterize
new parameters, and redefine motility disorders [4]. Motility disorders beyond achalasia now
include: esophagogastric junction outflow obstruction, major disorders of peristalsis (distal esophageal
spasm, hypercontractile esophagus, absent contractility) and minor disorders of peristalsis (ineffective
esophageal motility, fragmented peristalsis).
The aim of this study was to review the current diagnosis and management of esophageal motility
disorders beyond achalasia.
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2. HRM Parameters
2.1. Contractile Vigor—Distal Contractile Integral
HRM allows the evaluation of contractility through a combination of amplitude, time and length
of the peristaltic wave. This parameter is the distal contractile integral (DCI). DCI value is calculated
as the product of the mean amplitude of contraction in the distal esophagus (mmHg), the duration of
contraction (seconds), and the length of the distal esophageal segment (cm) exceeding 20 mmHg for the
region spanning from the transition zone to the proximal aspect of the lower esophageal sphincter (LES).
DCI classifies waves as failed (DCI < 100 mmHg/s/cm), weak (DCI 100–450 mmHg/s/cm), ineffective
(failed or weak), normal (DCI 450–8000 mmHg/s/cm) or hypercontractile (DCI > 8000 mmHg/s/cm).
2.2. Peristalsis—Distal Latency
HRM evaluates peristalsis by the distal latency (DL) which measures objectively the timeframe of
the wave from the beginning of the swallow (upper esophageal sphincter relaxation) to an inflection of
the peristaltic axis known as the contractile deceleration point. Premature contractions are defined
with a DL < 4.5 s.
Fragmented contractions are considered segmental defects (break in the 20-mmHg isobaric
contour > 5 cm) with normal contraction vigor.
2.3. Lower Esophageal Sphincter Pressure
The Chicago Classification did not define parameters for lower esophageal sphincter (LES) length
or basal pressure, but simply recommended assessment of pressure as an average of inspiratory and
expiratory values for three normal respiratory cycles. Relaxation, however, is measured not by the
nadir pressure, as previously done with conventional manometry, but with the integrated relaxation
pressure (IRP), which corresponds to the mean pressure of 4 s of greatest post deglutive relaxation in a
10 s gap, triggered at the beginning of a swallow.
3. Esophageal Motility Disorders beyond Achalasia
Esophagogastric Junction Outflow Obstruction
Esophagogastric junction (EGJ) outflow obstruction is characterized by an impaired LES relaxation
(IRP > 15 mmHg) with normal or weak peristalsis.
4. Major Disorders of Peristalsis
4.1. Distal Esophageal Spasm
Distal esophageal spasm (DES) is defined by premature contractions (DL < 4.5 s) in at least 20%
of swallows with a normal IRP (Figure 1).
4.2. Hypercontractile Esophagus
Hypercontractile esophagus (jackhammer esophagus) is characterized by
DCI > 8000 mmHg/s/cm in at least 20% of swallows and normal DL (Figure 2).
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Figure 1. Distal esophageal spasm. Premature contractions (DL < 4.5 s) in at least 20% of swallows. 
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mmHg/s/cm in at least 20% of swallows and normal DL (Figure 2). 
 
Figure 2. Hypercontractile esophagus (jackhammer esophagus). DCI > 8000 mmHg/s/cm in at least 
20% of swallows and normal DL. 
Figure 1. Distal esophageal spasm. Premature contractions (DL < 4.5 s) in at least 20% of swallows.
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4.3. Absent Contractility
Absent contractility is characterized by aperistalsis in the setting of normal LES relaxation
(IRP < 10 mmHg) (Figure 3).
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Ineffective esophageal motility is defined by ≥ 50% ineffective swallows (failed or weak—DCI < 
450 mmHg/s/cm) (Figure 4). 
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5.2. Fragmented Peristalsis 
Fragmented peristalsis is defined by ≥50% fragmented contractions with normal contraction 
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Figure 3. Absent contractility. Aperistalsis in the setting of normal LES relaxation (IRP < 10 mmHg).
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Figure 4. Ineffective esophageal motility. Failed or weak peristalsis in at least 30% of swallows.
5.2. Fragmented Peristalsis
Fragmented peristalsis is defined by ≥50% fragmented contractions with normal contraction
vigor (Figure 5).
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Figure 5. Fragmented peristalsis with a 7 cm gap. 
6. Management of Motility Disorders beyond Achalasia 
Esophagogastric Junction Outflow Obstruction 
The definition of EGJ outflow obstruction based solely on the IRP with the exclusion of achalasia 
allows this diagnosis to be superimposed to other diagnosis dependent on the esophageal body 
motility. It may be caused by an anatomical abnormality at the cardia (hiatal hernia, diseases of the 
esophageal wall, etc.) or be idiopathic with normal anatomy. 
Similar to achalasia, treatment is directed towards relief of the obstruction and can be 
accomplished by botulinum toxin injection, pneumatic dilatation (PD), laparoscopic Heller myotomy 
(LHM) or peroral endoscopic myotomy (POEM). Both botulinum injection and PD showed good 
relief of dysphagia but with ephemeral duration [5]. Scherer and colleagues [6], diagnosed 16 patients 
(1.6%) with EGJ outflow obstruction in doing 1000 HRM and treated them with botulinum toxin 
injection, PD or LHM. Only the three patients treated with LHM responded well. Interestingly, Pérez-
Fernández et al. [7] reported that over one-third of the patients with EGJ outflow obstruction 
presented a spontaneous resolution of the symptoms, concluding that surgical treatment should be 
considered with special caution in these patients. In the setting of an anatomic abnormality such as a 
hiatal hernia, surgical correction is associated with long-lasting and excellent results [8]. 
EGJ outflow obstruction is now recognized as a distinct entity in the Chicago Classification. 
However, the real clinical significance of this diagnosis is still uncertain. In fact, it could be an early 
or incomplete expression of a variant of achalasia. Thus, the exact significance and clinical 
management of these patients remains unclear. 
7. Major Disorders of Peristalsis 
As the symptoms and the manometric picture of esophageal motility disorders can be due to 
gastroesophageal reflux disease (GERD), it is of paramount importance to rule out abnormal reflux 
by pH monitoring. If GERD is present, either medical or surgical treatment should be directed 
towards the control of the reflux [9]. 
The management of DES remains elusive. The Chicago Classification defines this disorder with 
a new parameter: the distal latency (DL). Previous reports showed good results in patients with 
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6. Management of Motility Disorders beyond Achalasia
Esophagogastric Junction Outflow Obstruction
The definition of EGJ outflow obstruction based solely on the IRP with the exclusion of achalasia
allows this diagnosis to be superimposed to other diagnosis dependent on the esophageal body motility.
It may be caused by an anatomical abnormality at the cardia (hiatal hernia, diseases of the esophageal
wall, etc.) or be idiopathic with normal anatomy.
Similar to achalasia, treatment is directed towards relief of the obstruction and can be
accomplished by botulinum toxin injection, pneumatic dilatation (PD), laparoscopic Heller myotomy
(LHM) or peroral endoscopic myotomy (POEM). Both botulinum injection and PD showed good relief
of dysphagia but with ephemeral duration [5]. Scherer and colleagues [6], diagnosed 16 patients
(1.6%) with EGJ outflow obstruction in doing 1000 HRM and treated them with botulinum toxin
injection, PD or LHM. Only the three patients treated with LHM responded well. Interestingly,
Pérez-Fernández et al. [7] reported that over one-third of the patients with EGJ outflow obstruction
presented a spontaneous resolution of the symptoms, concluding that surgical treatment should be
considered with special caution in these patients. In the setting of an anatomic abnormality such as a
hiatal hernia, surgical correction is associated with long-lasting and excellent results [8].
EGJ outflow obstruction is now recognized as a distinct entity in the Chicago Classification.
However, the real clinical significance of this diagnosis is still uncertain. In fact, it could be an early or
incomplete expression of a variant of achalasia. Thus, the exact significance and clinical management
of these patients remains unclear.
7. Major Disorders of Peristalsis
As the symptoms and the manometric picture of esophageal motility disorders can be due to
gastroesophageal reflux disease (GERD), it is of paramount importance to rule out abnormal reflux by
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pH monitoring. If GERD is present, either medical or surgical treatment should be directed towards
the control of the reflux [9].
The management of DES remains elusive. The Chicago Classification defines this disorder
with a new parameter: the distal latency (DL). Previous reports showed good results in patients
with “diffuse esophageal spasm” (Richter classification) [10] who underwent LHM with an extended
myotomy [11,12]. However, scarce data are available after the new classification defined DES. A review
of the publications after this definition became publicized showed that botulinum toxin injection in the
esophageal body was superior to placebo to relieve dysphagia in patients with DES, and that POEM is
a promising treatment for these patients [13].
The definition of hypercontractile esophagus (jackhammer) was updated in the last version of the
Chicago Classification to include only cases with ≥20% of swallows with a DCI > 8000 mmHg/s/cm,
excluding a single altered swallow from the definition. Pharmacological relaxation of the smooth
muscle with phosphodiesterase-5 inhibitors or anticholinergic agents has shown symptomatic
improvement [14]. Studies focusing on surgical therapy for hypercontractile esophagus based on the
new classification are not available. Previous reports not using HRM or the Chicago Classification;
however, showed acceptable outcomes after surgical myotomy [15,16].
Absent contractility is mostly diagnosed in patients with connective tissue diseases. There is no
specific treatment to restore or improve peristalsis in these patients. Associated GERD is usually the
target of therapy [17].
8. Minor Disorders of Peristalsis
Therapeutic options for ineffective esophageal motility are still limited, as no effective treatment is
available to restore impaired esophageal smooth muscle contractility [18]. Treatment directed towards
gastroesophageal reflux disease is helpful when dysmotility is secondary to this disease.
The concept of fragmented peristalsis changed radically from previous versions to the version
3.0. Only large breaks (>5 cm) with normal peristalsis are included. This is more clinically relevant,
since incomplete bolus transit is observed in 100% of the cases of large breaks but only in 16% of small
breaks [19]. It is unclear how to treat this finding since there are no studies focusing on the treatment for
this disease under these criteria. There are no studies evaluating changes in the motility pattern after
therapy for gastroesophageal reflux disease as well, since both conditions are frequently associated.
9. Conclusions
HRM and the Chicago classification certainly contributed to a better definition of esophageal
motility disorders beyond achalasia. Although they have a much lower prevalence than achalasia, they
need to be considered in the differential diagnosis of a patient presenting with achalasia symptoms.
Unfortunately, the real clinical significance and correct management of these motility disorders are still
under investigation.
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